Dipa Karmakar serving 21-month doping suspension till July 2023

International
Testing
Agency
(ITA)
confirmed
the
development
on
Friday
as
it
mentioned
on
its
official
website
that
Dipa
Karmakar
tested
positive
for
higenamine.
ITA
further
mentioned
in
its
statement
that
Higenamine
is
a
stimulant
listed
under
Beta-2
Agonists
of
the
World
Anti-Doping
Agency
prohibited
list.

Higenamine
is
a
general
stimulant
that
helps
more
oxygen
intake
and
is
banned
both
in
and
out
competition.
Karmakar
is
yet
to
comment
on
the
matter.
ITA
said
they
collected
the
positive
sample
“on
behalf
of
the
Fédération
Internationale
de
Gymnastique
(FIG)
in
the
scope
of
an
out-of-competition
control
on
11
October
2021”.

ITA
further
mentioned
that
Karmakar’s
case
was
resolved
under
case
resolution
of
article
10.8.2
of
the
FIG
Anti-Doping
Rules
(FIG
ADR,
and
equivalent
provision
in
the
World
Anti-Doping
Code).

As
per
10.8.2
of
the
FIG
Anti-Doping
Rules
suggest
that
Karmakar
admitted
to
anti-doping
rule
violation
after
being
confronted
by
FIG
and
agrees
to
the
consequence
at
her
sole
discretion.

In
such
case,
the
athlete
“may
receive
a
reduction
in
the
period
of
Ineligibility
based
on
an
assessment
by
FIG
and
WADA
of
the
application
of
Articles
10.1
through
10.7
to
the
asserted
anti-doping
rule
violation,
the
seriousness
of
the
violation,
the
Athlete
or
other
Person’s
degree
of
Fault
and
how
promptly
the
Athlete
or
other
Person
admitted
the
violation;
and
(b)
the
period
of
Ineligibility
may
start
as
early
as
the
date
of
Sample
collection
or
the
date
on
which
another
anti-doping
rule
violation
last
occurred.”